252 related articles for article (PubMed ID: 14649771)
1. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
Long R; Bochar K; Chomyc S; Talbot J; Barrie J; Kunimoto D; Tilley P
Infect Control Hosp Epidemiol; 2003 Nov; 24(11):831-8. PubMed ID: 14649771
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
3. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
5. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
[TBL] [Abstract][Full Text] [Related]
6. New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture.
Ritchie SR; Harrison AC; Vaughan RH; Calder L; Morris AJ
Eur Respir J; 2007 Sep; 30(3):501-7. PubMed ID: 17537768
[TBL] [Abstract][Full Text] [Related]
7. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
8. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
Shibabaw A; Gelaw B; Wang SH; Tessema B
PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
[TBL] [Abstract][Full Text] [Related]
9. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Ambreen A; Jamil M; Rahman MAU; Mustafa T
BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
[TBL] [Abstract][Full Text] [Related]
10. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
[TBL] [Abstract][Full Text] [Related]
11. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
[TBL] [Abstract][Full Text] [Related]
12. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.
Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Mugerwa RD; Ellner JJ; Eisenach KD
Int J Tuberc Lung Dis; 2000 Jun; 4(6):528-36. PubMed ID: 10864183
[TBL] [Abstract][Full Text] [Related]
13. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
14. Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
Moraes ML; Ramalho DM; Delogo KN; Miranda PF; Mesquita ED; de Melo Guedes de Oliveira HM; Netto AR; Dos Anjos MJ; Kritski AL; de Oliveira MM
Biol Trace Elem Res; 2014 Aug; 160(2):176-84. PubMed ID: 24958018
[TBL] [Abstract][Full Text] [Related]
15. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
van der Kuyp F; Mahan CS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
[TBL] [Abstract][Full Text] [Related]
16. Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.
Sundaram V; Fujiwara PI; Driver CR; Osahan SS; Munsiff SS
Int J Tuberc Lung Dis; 2002 Mar; 6(3):238-45. PubMed ID: 11934142
[TBL] [Abstract][Full Text] [Related]
17. [Sputum smear conversion during intensive TB treatment phase according to HIV status, in hospitalised patients in Togo].
Wateba MI; Diop SA; Salou M; Womitso K; Nichols S; Tidjani O
Med Mal Infect; 2011 Mar; 41(3):140-4. PubMed ID: 21282024
[TBL] [Abstract][Full Text] [Related]
18. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
[TBL] [Abstract][Full Text] [Related]
19. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
20. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
Fortún J; Martín-Dávila P; Molina A; Navas E; Hermida JM; Cobo J; Gómez-Mampaso E; Moreno S
J Antimicrob Chemother; 2007 Apr; 59(4):794-8. PubMed ID: 17392354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
